Krebs Biochemicals & Industries has informed the exchange that the meeting of Board of Directors of the Company is scheduled to be held on Friday, 30th July 2021 to transact, the following: To consider and approve the unaudited financial results along with the Limited Review Report for the quarter ended 30th June, 2021 and Any other matter with the permission of the Chair.
The above information is a part of company’s filings submitted to BSE.